UNRESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA
Clinical trials for UNRESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could an arthritis drug boost chemo for pancreatic cancer?
Disease control Recruiting nowThis early-stage trial tests whether adding leflunomide (an arthritis drug) to standard chemotherapy (gemcitabine) is safe and effective for people with advanced pancreatic cancer that cannot be removed by surgery. About 19 adults will take part. The goal is to find the best dose…
Matched conditions: UNRESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New study aims to unlock pancreatic Cancer's weaknesses
Knowledge-focused Recruiting nowThis study is for people with pancreatic cancer that can be removed by surgery or has spread. Researchers want to see how different drugs change tumor biology by comparing biopsies taken before and after treatment. The goal is not to cure the disease now, but to learn which drugs…
Matched conditions: UNRESECTABLE PANCREATIC DUCTAL ADENOCARCINOMA
Phase: EARLY_PHASE1 • Sponsor: OHSU Knight Cancer Institute • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC